Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2017 (2017), Article ID 5804147, 10 pages
https://doi.org/10.1155/2017/5804147
Research Article

IGF-1 Gene Transfer to Human Synovial MSCs Promotes Their Chondrogenic Differentiation Potential without Induction of the Hypertrophic Phenotype

1Department of Orthopaedic Surgery, School of Medicine, Sapporo Medical University, Sapporo, Japan
2Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Suita, Japan
3McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, AB, Canada
4Department of Orthopedic Surgery, Saarland University Medical Center, Homburg, Saar, Germany
5Global Center for Medical Engineering and Informatics, Osaka University, Suita, Japan
6Institute for Medical Science in Sports, Osaka Health Science University, Osaka, Japan

Correspondence should be addressed to Norimasa Nakamura; pj.ca.usho@arumakan.asamiron

Received 28 February 2017; Accepted 7 May 2017; Published 27 June 2017

Academic Editor: Leonard M. Eisenberg

Copyright © 2017 Yasutoshi Ikeda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Rey-Rico, H. Madry, and M. Cucchiarini, “Hydrogel-based controlled delivery systems for articular cartilage repair,” BioMed Research International, vol. 2016, Article ID 1215263, 12 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Yasui, W. Ando, K. Shimomura et al., “Scaffold-free, stem cell-based cartilage repair,” Journal of Clinical Orthopaedics and Trauma, vol. 7, no. 3, pp. 157–163, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. A. W. Anz, A. Bapat, and W. D. Murrell, “Concepts in regenerative medicine: past, present, and future in articular cartilage treatment,” Journal of Clinical Orthopaedics and Trauma, vol. 7, no. 3, pp. 137–144, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Lyman, N. Nakamura, B. J. Cole, C. Erggelet, A. H. Gomoll, and J. Farr 2nd, “Cartilage-repair innovation at a standstill: methodologic and regulatory pathways to breaking free,” The Journal of Bone and Joint Surgery. American, vol. 98, no. 15, article e63, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. B. J. Huang, J. C. Hu, and K. A. Athanasiou, “Cell-based tissue engineering strategies used in the clinical repair of articular cartilage,” Biomaterials, vol. 98, pp. 1–22, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. J. C. Bernhard and G. Vunjak-Novakovic, “Should we use cells, biomaterials, or tissue engineering for cartilage regeneration?” Stem Cell Research & Therapy, vol. 7, no. 1, p. 56, 2016. View at Google Scholar
  7. E. B. Hunziker, “Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects,” Osteoarthritis and Cartilage, vol. 10, no. 6, pp. 432–463, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., “Multilineage potential of adult human mesenchymal stem cells,” Science, vol. 284, no. 5411, pp. 143–147, 1999. View at Google Scholar
  9. G. Filardo, H. Madry, M. Jelic, A. Roffi, M. Cucchiarini, and E. Kon, “Mesenchymal stem cells for the treatment of cartilage lesions: from preclinical findings to clinical application in orthopaedics,” Knee Surgery, Sports Traumatology, Arthroscopy, vol. 21, no. 8, pp. 1717–1729, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Sensebe, M. Krampera, H. Schrezenmeier, P. Bourin, and R. Giordano, “Mesenchymal stem cells for clinical application,” Vox Sanguinis, vol. 98, no. 2, pp. 93–107, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Squillaro, G. Peluso, and U. Galderisi, “Clinical trials with mesenchymal stem cells: an update,” Cell Transplantation, vol. 25, no. 5, pp. 829–848, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Wagner, F. Wein, A. Seckinger et al., “Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood,” Experimental Hematology, vol. 33, no. 11, pp. 1402–1416, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. H. S. Wang, S. C. Hung, S. T. Peng et al., “Mesenchymal stem cells in the Wharton’s jelly of the human umbilical cord,” Stem Cells, vol. 22, no. 7, pp. 1330–1337, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. C. De Bari, F. Dell'Accio, P. Tylzanowski, and F. P. Luyten, “Multipotent mesenchymal stem cells from adult human synovial membrane,” Arthritis and Rheumatism, vol. 44, no. 8, pp. 1928–1942, 2001. View at Publisher · View at Google Scholar
  15. M. Q. Wickham, G. R. Erickson, J. M. Gimble, T. P. Vail, and F. Guilak, “Multipotent stromal cells derived from the infrapatellar fat pad of the knee,” Clinical Orthopaedics and Related Research, vol. 412, pp. 196–212, 2003. View at Google Scholar
  16. G. Yu, X. Wu, M. A. Dietrich et al., “Yield and characterization of subcutaneous human adipose-derived stem cells by flow cytometric and adipogenic mRNA analyzes,” Cytotherapy, vol. 12, no. 4, pp. 538–546, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Sakaguchi, I. Sekiya, K. Yagishita, and T. Muneta, “Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source,” Arthritis and Rheumatism, vol. 52, no. 8, pp. 2521–2529, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Ando, K. Tateishi, D. A. Hart et al., “Cartilage repair using an in vitro generated scaffold-free tissue-engineered construct derived from porcine synovial mesenchymal stem cells,” Biomaterials, vol. 28, no. 36, pp. 5462–5470, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Koga, M. Shimaya, T. Muneta et al., “Local adherent technique for transplanting mesenchymal stem cells as a potential treatment of cartilage defect,” Arthritis Research & Therapy, vol. 10, no. 4, article R84, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Ezura, I. Sekiya, H. Koga, T. Muneta, and M. Noda, “Methylation status of CpG islands in the promoter regions of signature genes during chondrogenesis of human synovium-derived mesenchymal stem cells,” Arthritis and Rheumatism, vol. 60, no. 5, pp. 1416–1426, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Shimomura, W. Ando, K. Tateishi et al., “The influence of skeletal maturity on allogenic synovial mesenchymal stem cell-based repair of cartilage in a large animal model,” Biomaterials, vol. 31, no. 31, pp. 8004–8011, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. W. Ando, H. Fujie, Y. Moriguchi et al., “Detection of abnormalities in the superficial zone of cartilage repaired using a tissue engineered construct derived from synovial stem cells,” European Cells & Materials, vol. 24, pp. 292–307, 2012. View at Publisher · View at Google Scholar
  23. M. B. Schmidt, E. H. Chen, and S. E. Lynch, “A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair,” Osteoarthritis and Cartilage, vol. 14, no. 5, pp. 403–412, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. T. J. Huat, A. A. Khan, S. Pati, Z. Mustafa, J. M. Abdullah, and H. Jaafar, “IGF-1 enhances cell proliferation and survival during early differentiation of mesenchymal stem cells to neural progenitor-like cells,” BMC Neuroscience, vol. 15, p. 91, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. C. D. Oh and J. S. Chun, “Signaling mechanisms leading to the regulation of differentiation and apoptosis of articular chondrocytes by insulin-like growth factor-1,” The Journal of Biological Chemistry, vol. 278, no. 38, pp. 36563–36571, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Madry, G. Kaul, D. Zurakowski, G. Vunjak-Novakovic, and M. Cucchiarini, “Cartilage constructs engineered from chondrocytes overexpressing IGF-I improve the repair of osteochondral defects in a rabbit model,” European Cells & Materials, vol. 25, pp. 229–247, 2013. View at Publisher · View at Google Scholar
  27. J. Frisch, J. K. Venkatesan, A. Rey-Rico, G. Schmitt, H. Madry, and M. Cucchiarini, “Influence of insulin-like growth factor I overexpression via recombinant adeno-associated vector gene transfer upon the biological activities and differentiation potential of human bone marrow-derived mesenchymal stem cells,” Stem Cell Research & Therapy, vol. 5, no. 4, p. 103, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Marolt, M. Knezevic, and G. V. Novakovic, “Bone tissue engineering with human stem cells,” Stem Cell Research & Therapy, vol. 1, no. 2, p. 10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Kagami, H. Agata, and A. Tojo, “Bone marrow stromal cells (bone marrow-derived multipotent mesenchymal stromal cells) for bone tissue engineering: basic science to clinical translation,” The International Journal of Biochemistry & Cell Biology, vol. 43, no. 3, pp. 286–289, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Ando, K. Tateishi, D. Katakai et al., “In vitro generation of a scaffold-free tissue-engineered construct (TEC) derived from human synovial mesenchymal stem cells: biological and mechanical properties and further chondrogenic potential,” Tissue Engineering. Part A, vol. 14, no. 12, pp. 2041–2049, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Madry, D. Zurakowski, and S. B. Trippel, “Overexpression of human insulin-like growth factor-I promotes new tissue formation in an ex vivo model of articular chondrocyte transplantation,” Gene Therapy, vol. 8, no. 19, pp. 1443–1449, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Kanda, “Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics,” Bone Marrow Transplantation, vol. 48, no. 3, pp. 452–458, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. I. Sekiya, J. T. Vuoristo, B. L. Larson, and D. J. Prockop, “In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 7, pp. 4397–4402, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Li, T. Liu, N. Van Halm-Lutterodt, J. Chen, Q. Su, and Y. Hai, “Reprogramming of blood cells into induced pluripotent stem cells as a new cell source for cartilage repair,” Stem Cell Research & Therapy, vol. 7, p. 31, 2016. View at Google Scholar
  35. Y. Zhu, X. Wu, Y. Liang et al., “Repair of cartilage defects in osteoarthritis rats with induced pluripotent stem cell derived chondrocytes,” BMC Biotechnology, vol. 16, no. 1, p. 78, 2016. View at Google Scholar
  36. N. Koyama, M. Miura, K. Nakao et al., “Human induced pluripotent stem cells differentiated into chondrogenic lineage via generation of mesenchymal progenitor cells,” Stem Cells and Development, vol. 22, no. 1, pp. 102–113, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Tsumaki, M. Okada, and A. Yamashita, “iPS cell technologies and cartilage regeneration,” Bone, vol. 70, pp. 48–54, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Park and G. I. Im, “Embryonic stem cells and induced pluripotent stem cells for skeletal regeneration,” Tissue Engineering. Part B, Reviews, vol. 20, no. 5, pp. 381–391, 2014. View at Google Scholar
  39. A. Cheng, T. E. Hardingham, and S. J. Kimber, “Generating cartilage repair from pluripotent stem cells,” Tissue Engineering. Part B, Reviews, vol. 20, no. 4, pp. 257–266, 2014. View at Google Scholar
  40. Y. Yasui, R. Chijimatsu, D. A. Hart et al., “Preparation of scaffold-free tissue-engineered constructs derived from human synovial mesenchymal stem cells under low oxygen tension enhances their chondrogenic differentiation capacity,” Tissue Engineering. Part A, vol. 22, no. 5-6, pp. 490–500, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Gao, R. McBeath, and C. S. Chen, “Stem cell shape regulates a chondrogenic versus myogenic fate through Rac1 and N-cadherin,” Stem Cells, vol. 28, no. 3, pp. 564–572, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. D. Studer, C. Millan, E. Öztürk, K. Maniura-Weber, and M. Zenobi-Wong, “Molecular and biophysical mechanisms regulating hypertrophic differentiation in chondrocytes and mesenchymal stem cells,” European Cells and Materials, vol. 24, pp. 118–135, 2012. View at Publisher · View at Google Scholar
  43. J. Fischer, A. Aulmann, V. Dexheimer, T. Grossner, and W. Richter, “Intermittent PTHrP(1-34) exposure augments chondrogenesis and reduces hypertrophy of mesenchymal stromal cells,” Stem Cells and Development, vol. 23, no. 20, pp. 2513–2523, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. G. K. Kayabasi, R. S. Aydin, and M. Gumusderelioglu, “In vitro chondrogenesis by BMP6 gene therapy,” Journal of Biomedical Materials Research. Part A, vol. 101, no. 5, pp. 1353–1361, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Elsler, S. Schetting, G. Schmitt, D. Kohn, H. Madry, and M. Cucchiarini, “Effective, safe nonviral gene transfer to preserve the chondrogenic differentiation potential of human mesenchymal stem cells,” The Journal of Gene Medicine, vol. 14, no. 7, pp. 501–511, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Sakuma, M. A. Barry, and Y. Ikeda, “Lentiviral vectors: basic to translational,” The Biochemical Journal, vol. 443, no. 3, pp. 603–618, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. L. R. Goodrich, A. C. Chen, N. M. Werpy et al., “Addition of mesenchymal stem cells to autologous platelet-enhanced fibrin scaffolds in chondral defects: does it enhance repair?” The Journal of Bone and Joint Surgery. American, vol. 98, no. 1, pp. 23–34, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. K. Pelttari, A. Winter, E. Steck et al., “Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice,” Arthritis and Rheumatism, vol. 54, no. 10, pp. 3254–3266, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Koizumi, K. Ebina, D. A. Hart et al., “Synovial mesenchymal stem cells from osteo- or rheumatoid arthritis joints exhibit good potential for cartilage repair using a scaffold-free tissue engineering approach,” Osteoarthritis and Cartilage, vol. 24, no. 8, pp. 1413–1422, 2016. View at Publisher · View at Google Scholar · View at Scopus